The Lifecycle team were able to rise to the challenge of moving our organisations from SOC to FBC in 9 months. They were able to efficiently engage with all Trusts at all levels of the organisation and help us reach an agreed model for a shared the service that was externally challenged and verified and which has translated in early wins and cash-releasing savings. Without the Lifecycle team we would not have been able to get our organisations to work together in such a challenging timescale.
Lifecycle has played a key part in helping our three organisations complete both the OBC and FBC for Pathology consolidation in less than a year, despite the challenges posed by the COVID pandemic. Their experience and understanding of the challenges facing Pathology has meant that we able to get agreement on the best way forward fast.
Pathology has been an ongoing programme for NHS England with limited success being achieved in the last 10 years. In 2016, Chris and his team were instrumental in the design and initiation of launching the new 29 Pathology networks. This project has injected much needed pace in our consolidation efforts and is making great progress nationally.
The Lifecycle team has an unparallel knowledge of diagnostics and has been able to guide the team through the development of our procurement strategy and clinical specification development for a future-proof service.
When selecting our preferred pathology partner, Lewisham & Greenwich NHS Trust was faced with the unique challenge of having to decide between different NHS network options outside our local care system and a local private provider. Chris’ unique understanding of Pathology laboratories, the London Pathology market and the NHSI national consolidation programme, helped us navigate through this difficult decision-making process. The highly commended work completed by him and his team has led to us now being in the final stages of forming an ambitious partnership with Barts Health and Homerton University Hospital.
Kathleen and her team have helped us transform our direct access diagnostics. Through providing better management and coordination of contracts, negotiating cost reduction, identifying opportunities for efficiencies and implementing demand optimisation we have seen year-on-year reduction in activity and spend and improved patient pathways.